Clinical Trials Logo

Clinical Trial Summary

The OL1000 is intended to be used as a non-invasive adjunctive treatment for adult males or females that have sustained a closed, unstable ankle fracture that requires surgical treatment for stabilization. The initiation of the adjunctive treatment is to begin within 11 days of surgical stabilization.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02688855
Study type Interventional
Source Encore Medical, L.P.
Contact Akujuobi Udu, MS
Phone 248-914-0150
Email akujuobi.udu@djoglobal.com
Status Recruiting
Phase N/A
Start date January 23, 2017
Completion date June 2022